Anxiety · Hayward, CA
If you’re getting evaluated for anxiety for the first time, the appointment is usually not a full therapy session where you tell your entire life story. Your story matters, but the first visit needs a focused version: what you’re feeling, how long it’s been happening, what makes it worse, how it affects your life, and what kind of help you’re looking for. This is a primer on what to actually expect from a proper anxiety evaluation — and equally important, what not to expect.
The structural reason this matters: anxiety disorders are the most common mental health condition globally, affecting an estimated 4% of the world population at any given time per WHO surveillance and approximately 31% of U.S. adults across the lifespan per the National Comorbidity Survey Replication.[1][2] Most cases never get a proper evaluation. Many of the cases that do get evaluated get rushed treatment based on a fifteen-minute appointment. Both outcomes are bad. A good evaluation takes the time to understand what your nervous system is actually doing.
A strong anxiety evaluation should leave you with more clarity, not more shame.
Why diagnosis takes more than “I feel anxious”
Anxiety presents differently in different people. For one person it’s constant background worry. For another it’s discrete panic episodes in the body — heart racing, chest tight, the sense of being about to faint or die. For another it’s avoidance of social situations because judgment feels unbearable. For another it looks like irritability and short fuse, which doesn’t get recognized as anxiety at all. Some people look obviously nervous. Others look calm while their mind is racing.
Anxiety can also come from many sources. It may be generalized anxiety disorder. It may be panic disorder, social anxiety disorder, specific phobia, obsessive-compulsive disorder, post-traumatic stress disorder, or generalized anxiety as a feature of depression rather than a primary disorder. It may also come from ADHD (the cumulative anxiety of years of unsupported executive dysfunction), sleep disorders, substance use including caffeine, medication side effects, or medical conditions like hyperthyroidism, cardiac arrhythmia, or anemia that make the body feel alarmed.
The current authoritative synthesis of this literature is the Craske, Stein, Eley and colleagues 2017 review in Nature Reviews Disease Primers, which frames anxiety disorders as a family of related conditions sharing core features of fear and anxiety but differing in their triggers, presentations, and treatment-relevant subtypes.[3] A good clinician doesn’t treat “anxiety” as a single thing. They figure out which kind, in what pattern, against what background.
What the appointment actually involves
An adequate first appointment is mostly questions. Expect to be asked:
When the anxiety started, and what was happening in your life at that time. Onset in childhood vs. adolescence vs. adulthood often points to different underlying conditions. Onset after a specific trauma or major stressor narrows the differential further.
What the anxiety actually feels like. Body-centered (panic, somatic symptoms) vs. cognition-centered (worry, rumination) vs. social-evaluation-centered (judgment, embarrassment) — these are all “anxiety” but they point to different diagnoses.
What you avoid. Avoidance is often more diagnostic than the fear itself. Avoiding crowds is different from avoiding specific situations is different from avoiding starting tasks is different from avoiding intrusive thoughts. The pattern of avoidance helps clarify the underlying condition.
What you fear will happen. The content of the feared outcome — judgment, panic, contamination, harm coming to a loved one, embarrassing yourself, dying — sorts anxiety presentations into clinically meaningful subgroups.
How you sleep. Sleep is bidirectionally entangled with anxiety. Sleep deprivation can mimic or worsen anxiety; anxiety often disrupts sleep onset and maintenance. A clinician who doesn’t ask is missing data.
What substances and medications you use, including caffeine, alcohol, cannabis, and prescription stimulants. All of these can produce or worsen anxiety symptoms. Some can mimic anxiety disorders entirely.
Whether you have other mental or physical health symptoms. Depression and anxiety co-occur at high rates. Anxiety can also be the presenting symptom of a medical condition rather than a primary psychiatric one. A thoughtful clinician screens for both.
You don’t need perfect answers to any of these. The point is to help the clinician understand the shape of the anxiety.
You are not unusual. The evaluation should treat you that way.
Per the National Comorbidity Survey Replication (Kessler 2005), approximately 31% of U.S. adults meet criteria for an anxiety disorder during their lifetime. The WHO estimates 4% of the global population is affected at any given time.
Despite the scale, most cases never receive a proper evaluation. Many that do get rushed — fifteen-minute appointment, single questionnaire, immediate prescription. That isn’t an evaluation. It’s a transaction.
Why questionnaires may be used — and what they can’t do
Many clinicians use validated screening tools as part of the intake. The most common for generalized anxiety is the GAD-7, developed by Spitzer, Kroenke, Williams and Löwe and published in Archives of Internal Medicine in 2006 as a seven-item self-report measure of generalized anxiety disorder severity.[4] A 2016 systematic review and diagnostic meta-analysis by Plummer and colleagues in General Hospital Psychiatry confirmed the GAD-7 (and shortened GAD-2) as reasonable initial screens not just for GAD but also for panic disorder, social anxiety disorder, and PTSD, with appropriate cutoff scores.[5]
These tools are useful because they create a measurable starting point — a number you can track to see whether treatment is working. They are not the whole diagnosis. A GAD-7 score of 12 doesn’t tell you whether the anxiety is being driven by primary GAD, by undiagnosed ADHD generating constant anxiety, by trauma response, or by a medical issue. The score is a tool. The clinical interview is the diagnosis.
Be cautious of any clinical setting that gives you a single questionnaire, hands you a prescription, and considers the appointment complete. That isn’t an evaluation. It’s a transaction.
Don’t expect every answer on the first visit
Sometimes the diagnosis is clear within the first appointment. Other times it isn’t, and that’s actually a good sign — it usually means the clinician is being careful rather than forcing you into the first plausible category.
Mental health symptoms overlap. Two people who both report “I have anxiety” can need very different treatment plans depending on the underlying drivers. That’s why the first appointment may be the start of a process rather than the final answer. Treatment may take some trial and adjustment before the right fit becomes clear. That’s frustrating when you’re suffering now. It’s not evidence that you’re doing anything wrong, and it’s not evidence that recovery isn’t possible. It usually means your specific pattern is being taken seriously.
What a good anxiety evaluation actually asks
Bring rough answers to these seven dimensions. You don’t need perfect answers — the point is to help the clinician understand the shape of your anxiety.
What treatment typically looks like — and what it doesn’t
Medication is one possible component of anxiety care, not the entire plan. The UK’s National Institute for Health and Care Excellence (NICE) clinical guideline 113 for generalized anxiety disorder and panic disorder in adults describes a stepped-care approach: care typically begins with education, self-help materials, and lower-intensity interventions, then steps up to high-intensity psychological therapy (typically cognitive-behavioral therapy with exposure components) or medication (typically SSRI or SNRI) depending on severity and patient preference.[6] The American Psychiatric Association’s DSM-5-TR framework is consistent with this general approach for the major anxiety disorders.[7]
For most anxiety disorders, the evidence-based options are:
Cognitive-behavioral therapy (CBT), especially when it includes exposure-based components for specific anxiety disorders (panic disorder, social anxiety, OCD, PTSD, specific phobia). Exposure work is one of the most robustly supported psychological treatments in clinical psychiatry.
SSRIs and SNRIs for generalized anxiety, panic disorder, social anxiety, OCD, and PTSD. Sertraline, escitalopram, paroxetine, venlafaxine, and duloxetine all have evidence supporting their use, with the specific choice driven by individual factors (prior response, side effect profile, comorbidities, drug interactions).
Buspirone for generalized anxiety disorder as a non-controlled, non-sedating option. Slower to take effect than benzodiazepines and with smaller effect size, but well-tolerated and without dependence risk.
Short-term benzodiazepines in carefully selected situations. Useful for acute panic or as a bridge while an SSRI takes effect, but problematic as a long-term solution because of tolerance, dependence, and rebound anxiety.
Lifestyle interventions that are not optional in serious treatment: sleep regularization, exercise, caffeine reduction, alcohol moderation, and sometimes a careful look at cannabis use.
A note on what is not a typical first-line anxiety treatment: TMS is primarily FDA-cleared for major depressive disorder, with a more recent clearance for anxious depression (depression with anxiety symptoms) via Deep TMS in 2021. It is not a broadly indicated anxiety treatment. SPRAVATO (esketamine) is FDA-approved for treatment-resistant depression in adults — both as monotherapy (approved January 21, 2025) and in combination with an oral antidepressant — not as a general anxiety treatment. These options may become relevant when depression is also part of the picture, but they’re not the starting point for anxiety alone.
What the score actually means
The GAD-7 (Spitzer, Kroenke, Williams & Löwe 2006) is a 7-item self-report. Total score 0–21. Severity bands from the original validation.
What the score CAN’T do: tell you which kind of anxiety, what’s driving it, whether it’s primary or secondary to depression, ADHD, trauma, or medical illness. The score is a tool. The clinical interview is the diagnosis.
What a good evaluation should leave you with
A strong evaluation, whether it concludes in one visit or unfolds across two or three, should leave you with at least four things:
A working diagnosis — what your clinician thinks is going on, named in terms specific enough to be clinically useful. “You have anxiety” is not a working diagnosis. “You have generalized anxiety disorder with prominent somatic features, and we need to rule out hyperthyroidism” is.
An understanding of what else might be contributing — the comorbid conditions, lifestyle factors, medical considerations, and life-stress drivers that might be making the primary condition worse.
A treatment plan with stages and decision points — what we’re doing first, what we expect from it, how long before we evaluate, and what comes next if it doesn’t help enough.
A baseline measure — typically a validated rating scale score (GAD-7, PCL-5, Y-BOCS, etc.) so you can both tell whether things are objectively improving rather than just relying on whether the week felt better.
If you leave an evaluation without those four things, the evaluation wasn’t finished — even if the appointment was.
What treatment usually looks like, step by step
UK NICE clinical guideline 113 frames anxiety care as stepped — start with the least intensive intervention that’s likely to help, step up if needed. Most U.S. care follows the same logic.
Understanding the condition, self-help materials, sleep/caffeine/alcohol changes. May resolve mild cases.
Guided self-help (book or app-based CBT), psychoeducational groups. Often delivered by a primary care or community provider.
Full CBT (often with exposure components for specific disorders), SSRI or SNRI medication. Specialist involvement.
Combined CBT + medication, additional augmentation strategies, addressing comorbid conditions. For severe or treatment-refractory cases.
The goal of the diagnostic appointment
The goal isn’t to prove that you’re “an anxious person.” It’s to understand what your nervous system is doing, what it’s trying to protect you from, and what kind of care would actually fit your specific situation. A strong evaluation should leave you with more clarity, not more shame.
Anxiety can make everything feel urgent and confusing. The diagnostic appointment is supposed to slow that down enough to ask the right questions: what’s actually happening, what’s driving it, what else could be contributing, and what treatment path gives you the best chance of getting better.
If you’ve had appointments that didn’t do that, the issue is not that anxiety can’t be diagnosed — it’s that the appointment didn’t include the work a real evaluation requires.
If you’ve had appointments that didn’t slow down enough to ask the right questions, that’s not on you.
References
- World Health Organization. Anxiety Disorders. WHO Fact Sheet. Available at who.int/news-room/fact-sheets/detail/anxiety-disorders.
- Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 Jun;62(6):593-602. PMID: 15939837.
- Craske MG, Stein MB, Eley TC, et al. Anxiety disorders. Nat Rev Dis Primers. 2017 May 4;3:17024. PMID: 28880065. doi:10.1038/nrdp.2017.24.
- Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. PMID: 16717171. doi:10.1001/archinte.166.10.1092.
- Plummer F, Manea L, Trepel D, McMillan D. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry. 2016 Mar-Apr;39:24-31. PMID: 26719105. doi:10.1016/j.genhosppsych.2015.11.005.
- National Institute for Health and Care Excellence (NICE). Generalised anxiety disorder and panic disorder in adults: management. Clinical guideline CG113. Available at nice.org.uk/guidance/cg113.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Anxiety Disorders diagnostic criteria. Washington, DC: APA; 2022.

Comments are closed